Interleukin-1 gene cluster polymorphisms in cerebral infarction

Cytokine

Volumn 23, Issue 1-2, 2003, Pages 41-46

  Um, Jae Young ^a,b   Moon, Kyung Suk ^a   Lee, Kang Min ^b   Kim, Hyung Min ^a  

^a Kyung Hee University   (South Korea)

^b Chonbuk National University   (South Korea)

Author keywords

Cerebral infarction; Interleukin 1; Polymorphism

Indexed keywords

INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA;

ADULT; AGED; ALLELE; ARTICLE; BRAIN INFARCTION; CONTROLLED STUDY; DNA POLYMORPHISM; FEMALE; GENE CLUSTER; GENOTYPE; HUMAN; KOREA; MAJOR CLINICAL STUDY; MALE; PATHOGENESIS; PRIORITY JOURNAL;

EID: 0042594440     PISSN: 10434666     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1043-4666(03)00183-2     Document Type: Article

References (44)

1. Stoll G., Jander S., Schroeter M. Inflammation and glial responses in ischemic brain lesions. Prog Neurobiol. 56:1988;149-171.
2. Dinarello C.A. Biologic basis for interleukin-1 in disease. Blood. 87:1996;2095-2147.
3. McDowell T.L., Symons J.A., Ploski R., Forre O., Duff G.W. A genetic association between juvenile rheumatoid arthritis and a novel interleukin-1 alpha polymorphism. Arthritis Rheum. 38:1995;221-228.
4. Di Giovine F.S., Takhsh E., Blakemore A.I., Duff G.W. Single base polymorphism at -511 in the human interleukin-1 beta gene (IL1 beta). Hum Mol Genet. 1:1992;450.
5. Bioque G., Crusius J.B., Koutroubakis I., Bouma G., Kostense P.J., Meuwissen S.G., et al. Allelic polymorphism in IL-1 beta and IL-1 receptor antagonist (IL-1Ra) genes in inflammatory bowel disease. Clin Exp Immunol. 102:1995;379-383.
6. Tarlow J.K., Blakemore A.I., Lennard A., Solari R., Hughes H.N., Steinkasserer A., et al. Polymorphism in human IL-1 receptor antagonist gene intron 2 is caused by variable numbers of an 86-bp tandem repeat. Hum Genet. 91:1993;403-404.
7. Danis V.A., Millington M., Hyland V.J., Grennan D. Cytokine production by normal human monocytes: inter-subject variation and relationship to an IL-1 receptor antagonist (IL-1Ra) gene polymorphism. Clin Exp Immunol. 99:1995;303-310.
8. Santtila S., Savinainen K., Hurme M. Presence of the IL-1RA allele 2 (IL1RN*2) is associated with enhanced IL-1 beta production in vitro. Scand J Immunol. 47:1998;195-198.
9. Pociot F., Molvig J., Wogensen L., Worsaae H., Nerup J. A TaqI polymorphism in the human interleukin-1 beta (IL-1 beta) gene correlates with IL-1 beta secretion in vitro. Eur J Clin Invest. 22:1992;396-402.
10. Tountas N.A., Casini-Raggi V., Yang H., Di Giovine F.S., Vecchi M., Kam L., et al. Functional and ethnic association of allele 2 of the interleukin-1 receptor antagonist gene in ulcerative colitis. Gastroenterology. 117:1999;806-813.
11. Hurme M., Santtila S. IL-1 receptor antagonist (IL-1Ra) plasma levels are co-ordinately regulated by both IL-1Ra and IL-1 beta genes. Eur J Immunol. 28:1998;2598-2602.
12. Sciacca F.L., Ferri C., Vandenbroeck K., Veglia F., Gobbi C., Martinelli F., et al. Relevance of interleukin 1 receptor antagonist intron 2 polymorphism in Italian MS patients. Neurology. 52:1999;1896-1898.
13. Dominici R., Cattaneo M., Malferrari G., Archi D., Mariani C., Grimaldi L., et al. Cloning and functional analysis of the allelic polymorphism in the transcription regulatory region of interleukin 1-α Immunogenetics. 54:2002;82-86.
14. Ross R. Atherosclerosis: an inflammatory disease. N Engl J Med. 340:1999;115-126.
15. Woods A., Brull D.J., Humphries S.E., Montgomery H.E. Genetics of inflammation and risk of coronary artery disease: the central role of interleukin-6. Eur Heart J. 21:2000;1574-1583.
16. Andreotti F., Porto I., Crea F., Maseri A. Inflammatory gene polymorphisms and ischaemic heart disease: review of population association studies. Heart. 87:2002;107-112.
17. Rothwell N.J., Luheshi G.N. Interleukin 1 in the brain: biology, pathology and therapeutic target. Trends Neurosci. 23:2000;618-625.
18. Stroemer R.P., Rothwell N.J. Exacerbation of ischemic brain damage by localized striatal injection of interleukin-1 beta in the rat. J Cereb Blood Flow Metab. 18:1998;833-839.
19. Hillhouse E.W., Kida S., Iannotti F. Middle cerebral artery occlusion in the rat causes a biphasic production of immunoreactive interleukin-1 beta in the cerebral cortex. Neurosci Lett. 249:1998;177-179.
20. Wang X., Yue T.L., Barone F.C., White R.F., Gagnon R.C., Feuerstein G.Z. Concomitant cortical expression of TNF-alpha and IL-1 beta mRNAs follows early response gene expression in transient focal ischemia. Mol Chem Neuropathol. 23:1994;103-114.
21. Zhang Z., Chopp M., Goussev A., Powers C. Cerebral vessels express interleukin 1beta after focal cerebral ischemia. Brain Res. 784:1998;210-217.
22. Allan S.M., Parker L.C., Collins B., Davies R., Luheshi G.N., Rothwell N.J. Cortical cell death induced by IL-1 is mediated via actions in the hypothalamus of the rat. Proc Natl Acad Sci U S A. 97:2000;5580-5585.
23. Lawrence C.B., Allan S.M., Rothwell N.J. Interleukin-1β and the interleukin-1 receptor antagonist act in the striatum to modify excitotoxic brain damage in the rat. Eur J Neurosci. 10:1998;1188-1195.
24. Loddick S.A., Rothwell N.J. Neuroprotective effects of human recombinant interleukin-1 receptor antagonist in focal cerebral ischaemia in the rat. J Cereb Blood Flow Metab. 16:1996;932-940.
25. Betz A.L., Yang G.Y., Davidson B.L. Attenuation of stroke size in rats using an adenoviral vector to induce overexpression of interleukin-1 receptor antagonist in brain. J Cereb Blood Flow Metab. 15:1995;547-551.
26. Garcia J.H., Liu K.F., Relton J.K. Interleukin-1 receptor antagonist decreases the number of necrotic neurons in rats with middle cerebral artery occlusion. Am J Pathol. 147:1995;1477-1486.
27. Lin M.T., Kao T.Y., Jin Y.T., Chen C.F. Interleukin-1 receptor antagonist attenuates the heat stroke-induced neuronal damage by reducing the cerebral ischemia in rats. Brain Res Bull. 37:1995;595-598.
28. Yang G.Y., Liu X.H., Kadoya C., Zhao Y.J., Mao Y., Davidson B.L., et al. Attenuation of ischemic inflammatory response in mouse brain using an adenoviral vector to induce overexpression of interleukin-1 receptor antagonist. J Cereb Blood Flow Metab. 18:1998;840-847.
29. Du Y., Dodel R.C., Eastwood B.J., Bales K.R., Gao F., Lohmuller F., et al. Association of an interleukin lα polymorphism with Alzheimer's disease. Neurology. 55:2000;480-483.
30. Grimaldi L.M.E., Casadei V.M., Ferri C., Veglia F., Licastro F., Annoni G., et al. Association of early-onset Alzheimer's disease with an interleukin-lα gene polymorphism. Ann Neurol. 47:2000;361-365.
31. Nicoll J.A.R., Mrak R.E., Graham D., Stewart J., Cole G.M., Yang F.S., et al. Association of interleukin-1 gene polymorphisms with Alzheimer's disease. Ann Neurol. 47:2000;365-368.
32. Rebeck G.W. Confirmation of the genetic association of interleukin-1α with early onset sporadic Alzheimer's disease. Neurosci Lett. 293:2000;75-77.
33. Ki C.S., Na D.L., Kim D.K., Kim H.J., Kim J.W. Lack of association of the interleukin-1α gene polymorphism with Alzheimer's disease in a Korean population. Ann Neurol. 49:2001;817-818.
34. Kolsch H., Ptok U., Bagli M., Papassotiropoulos Schmitz A.S., Barkow K., Kockler M., et al. Gene polymorphisms of interleukin-1alpha influence the course of Alzheimer's disease. Ann Neurol. 49:2001;818-819.
35. Minster R.L., DeKosky S.T., Ganguli M., Belle S., Kamboh M.I. Genetic association studies of interleukin-1 (IL-1A and IL-1B) and interleukin-1 receptor antagonist genes and the risk of Alzheimer's disease. Ann Neurol. 48:2000;817-819.
36. Murphy G.M. Jr., Claassen J.D., DeVoss J.J., Pascoe N., Taylor J., Tinklenberg J.R., et al. Rate of cognitive decline in AD is accelerated by the interleukin-1 alpha -889 *1 allele. Neurology. 56:2001;1595-1597.
37. Schulte T., Schols L., Muller T., Woitalla D., Berger K., Kruger R. Polymorphisms in the interleukin-1 alpha and beta genes and the risk for Parkinson's disease. Neurosci Lett. 326:2002;70-72.
38. Luomala M., Lehtimaki T., Elovaara I., Wang X., Ukkonen M., Mattila K., et al. A study of interleukin-1 cluster genes in susceptibility to and severity of multiple sclerosis. J Neurol Sci. 185:2001;123-127.
39. Wilkinson R.J., Patel P., Llewelyn M., Hirsch C.S., Pasvol G., Snounou G., et al. Influence of polymorphism in the genes for the interleukin (IL)-1 receptor antagonist and IL-1beta on tuberculosis. J Exp Med. 189:1999;1863-1874.
40. Dewberry R., Holden H., Crossman D., Francis S. Interleukin-1 receptor antagonist expression in human endothelial cells and atherosclerosis. Arterioscler Thromb Vasc Biol. 20:2000;2394-2400.
41. Clay F.E., Tarlow J.K., Cork M.J., Cox A., Nicklin M.J., Duff G.W. Novel interleukin-1 receptor antagonist exon polymorphisms and their use in allele-specific mRNA assessment. Hum Genet. 97:1996;723-726.
42. Ishihara Y., Nishihara T., Kuroyanagi T., Shirozu N., Yamagishi E., Ohguchi M., et al. Gingival crevicular interleukin-1 and interleukin-1 receptor antagonist levels in periodontally healthy and diseased sites. J Periodontal Res. 32:1997;524-529.
43. Miller S.A., Dykes D.D., Polesky H.F. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res. 16:1988;1215.
44. Foster C.B., Lehrnbecher T., Samuels S., Stein S., Mol F., Metcalf J.A., et al. An IL6 promoter polymorphism is associated with a lifetime risk of development of Kaposi sarcoma in men infected with human immunodeficiency virus. Blood. 96:2000;2562-2567.